1.A six months old neglected anterior shoulder dislocation managed by closed reduction and Latarjet procedure.
Deepak CHAUDHARY ; Deepak JOSHI ; Vineet JAIN ; Mukul MOHINDRA ; Nitin MEHTA
Chinese Journal of Traumatology 2016;19(5):295-297
A neglected shoulder dislocation is a rarer entity and only few cases are reported in the literature. An anterior dislocation of the shoulder is rarely missed as patients present with limb in abduction and external rotation, an attitude very familiar to orthopaedic surgeon. Occasionally such cases are missed when they present with fracture of proximal humerus or when they receive treatment from unqualified practitioners who commonly practise in rural areas. Owing to very few reports there is paucity of literature and no standard treatment protocol exists for neglected anterior dislocation of the shoulder, though most such chronic cases are managed by open reduction. This case report describes a six months old neglected anterior dislocation with a significant Hill Sachs lesion, which was managed by closed reduction and Latarjet procedure.
Adult
;
Humans
;
Male
;
Orthopedic Procedures
;
methods
;
Shoulder Dislocation
;
diagnostic imaging
;
surgery
2.Impact of COVID-19 Pandemic on People with Locomotor Disability in North India: A Cross-Sectional Analysis
Siddharth RAI ; Harleen UPPAL ; Mallikarjun GUNJIGANVI ; Nitin JOSHI ; Prabhaker MISHRA
Annals of Rehabilitation Medicine 2024;48(1):94-101
Objective:
To assess, analyse, and infer the impact of the coronavirus disease 2019 (COVID-19) pandemic on people living with locomotor disability in North India.
Methods:
Patients with locomotor disabilities who met the inclusion criteria received a questionnaire that had already undergone testing and validation. It covered topics highlighting the effect of the pandemic on general health, financial burden, psychological and mental health, social life and behaviour, disability and comorbidity management, transportation, and healthcare accessibility during the pandemic. In order to gauge the pandemic’s effects on the population of people with locomotor disabilities, the answers to the questions were collected and analyzed.
Results:
The COVID-19 pandemic has adversely affected people living with locomotor disability, ranging from loss of wages and financial crisis to anxiety, depression and lack of sleep. People with disabilities had limited reach to health and community services that were vital for them, including basic life and functional needs, besides risks of mistreatment and other psychological consequences.
Conclusion
This analysis suggests that the root cause of pandemic disparities is the lack of disability-inclusive planning and, more significantly, the pre-existing socioeconomic disparities and challenges that disabled people have been experiencing for a long time. We suggest that unambiguous public health and policy responses should be incorporated, and health, social participation, and socioeconomic disparity causes for disabled people should be addressed in tandem.
3.Achalasia Cardia Subtyping by High-Resolution Manometry Predicts the Therapeutic Outcome of Pneumatic Balloon Dilatation.
Nitesh PRATAP ; Rakesh KALAPALA ; Santosh DARISETTY ; Nitin JOSHI ; Mohan RAMCHANDANI ; Rupa BANERJEE ; Sandeep LAKHTAKIA ; Rajesh GUPTA ; Manu TANDAN ; G V RAO ; D Nageshwar REDDY
Journal of Neurogastroenterology and Motility 2011;17(1):48-53
BACKGROUND/AIMS: High-resolution manometry (HRM) with pressure topography is used to subtype achalasia cardia, which has therapeutic implications. The aim of this study was to compare the clinical characteristics, manometric variables and treatment outcomes among the achalasia subtypes based on the HRM findings. METHODS: The patients who underwent HRM at the Asian Institute of Gastroenterology, Hyderabad between January 2008 and January 2009 were enrolled. The patients with achalasia were categorized into 3 subtypes: type I - achalasia with minimum esophageal pressurization, type II - achalasia with esophageal compression and type III - achalasia with spasm. The clinical and manometric variables and treatment outcomes were compared. RESULTS: Eighty-nine out of the 900 patients who underwent HRM were diagnosed as achalasia cardia. Fifty-one patients with a minimum follow-up period of 6 months were included. Types I and II achalasia were diagnosed in 24 patients each and 3 patients were diagnosed as type III achalasia. Dysphagia and regurgitation were the main presenting symptoms in patients with types I and II achalasia. Patients with type III achalasia had high basal lower esophageal sphincter pressure and maximal esophageal pressurization when compared to types I and II. Most patients underwent pneumatic dilatation (type I, 22/24; type II, 20/24; type III, 3/3). Patients with type II had the best response to pneumatic dilatation (18/20, 90.0%) compared to types I (14/22, 63.3%) and III (1/3, 33.3%). CONCLUSIONS: The type II achalasia cardia showed the best response to pneumatic dilatation.
Asian Continental Ancestry Group
;
Cardia
;
Deglutition Disorders
;
Dilatation
;
Esophageal Achalasia
;
Esophageal Motility Disorders
;
Esophageal Sphincter, Lower
;
Follow-Up Studies
;
Gastroenterology
;
Humans
;
Manometry
;
Spasm
4.Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases.
Jingjing GAO ; Ziting XIA ; Dilrasbonu VOHIDOVA ; John JOSEPH ; James N LUO ; Nitin JOSHI
Acta Pharmaceutica Sinica B 2023;13(4):1400-1428
Emerging therapies based on localized delivery of siRNA to lungs have opened up exciting possibilities for treatment of different lung diseases. Localized delivery of siRNA to lungs has shown to result in severalfold higher lung accumulation than systemic route, while minimizing non-specific distribution in other organs. However, to date, only 2 clinical trials have explored localized delivery of siRNA for pulmonary diseases. Here we systematically reviewed recent advances in the field of pulmonary delivery of siRNA using non-viral approaches. We firstly introduce the routes of local administration and analyze the anatomical and physiological barriers towards effective local delivery of siRNA in lungs. We then discuss current progress in pulmonary delivery of siRNA for respiratory tract infections, chronic obstructive pulmonary diseases, acute lung injury, and lung cancer, list outstanding questions, and highlight directions for future research. We expect this review to provide a comprehensive understanding of current advances in pulmonary delivery of siRNA.